ESMO Virtual Congress 2020

19.-21. September 2020

Teilnehmer: Dr. Andriy Krendyukov, VP Medical Affairs


Cambridge Healthtech Institute's 8th Annual Immuno-Oncology Virtual Summit

6.-8. Oktober 2020

Teilnehmer: Dr. Katharina Billian-Frey, Head of Protein Engineering

Präsentation: 7. Oktober, 13:15 Uhr EDT: "HERA-CD40L: A Two-Fold-Three-Based CD40 Agonist for Cancer Immunotherapy"
(Session: Emerging Targets and Combinations to Overcome Resistance to Immune Therapy)


Präsentationen und Poster von vergangenen Konferenzen

AACR Virtual Annual Meeting II

22.-24. Juni 2020

Poster #4460: Novel bispecific molecules combining HERA-CD40L with anti-CEA or with anti-PD-L1 for targeting

Poster #4529: Neutralization of pro-apoptotic CD95L by Asunercept/APG101 does not impair anti-tumor immune responses

Präsentation #1076: Hexavalent HERA-CD40L induces a productive T cell-mediated anti-tumor immune response and shows superior activity in comparison to benchmark CD40 agonistic antibodies